Bahl & Gaynor’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.94M Sell
8,554
-702
-8% -$355K 0.02% 181
2025
Q4
$5.24M Sell
9,256
-72
-0.8% -$38.3K 0.03% 175
2025
Q3
$4.17M Sell
9,328
-243
-3% -$117K 0.02% 182
2025
Q2
$5.2M Sell
9,571
-237
-2% -$124K 0.03% 173
2025
Q1
$4.86M Sell
9,808
-220
-2% -$122K 0.02% 173
2024
Q4
$5.23M Sell
10,028
-217
-2% -$113K 0.03% 168
2024
Q3
$5.03M Sell
10,245
-486
-5% -$226K 0.03% 174
2024
Q2
$4.77M Sell
10,731
-552
-5% -$220K 0.03% 171
2024
Q1
$4.5M Sell
11,283
-373
-3% -$141K 0.03% 174
2023
Q4
$3.93M Buy
11,656
+570
+5% +$170K 0.02% 175
2023
Q3
$3.24M Sell
11,086
-874
-7% -$273K 0.02% 178
2023
Q2
$4.09M Sell
11,960
-171
-1% -$51.7K 0.02% 171
2023
Q1
$3.1M Buy
12,131
+67
+0.6% +$16.5K 0.02% 184
2022
Q4
$3.2M Sell
12,064
-796
-6% -$194K 0.02% 177
2022
Q3
$2.41M Sell
12,860
-145
-1% -$31.1K 0.02% 193
2022
Q2
$2.61M Sell
13,005
-494
-4% -$116K 0.02% 196
2022
Q1
$4.07M Sell
13,499
-157
-1% -$45.9K 0.03% 172
2021
Q4
$4.91M Sell
13,656
-1,356
-9% -$467K 0.03% 173
2021
Q3
$4.97M Sell
15,012
-2,055
-12% -$690K 0.03% 165
2021
Q2
$5.23M Sell
17,067
-570
-3% -$160K 0.03% 161
2021
Q1
$4.34M Sell
17,637
-135
-0.8% -$34K 0.03% 175
2020
Q4
$4.85M Sell
17,772
-396
-2% -$98.3K 0.03% 158
2020
Q3
$4.3M Sell
18,168
-1,770
-9% -$397K 0.03% 153
2020
Q2
$3.79M Sell
19,938
-5,601
-22% -$1M 0.03% 158
2020
Q1
$4.22M Sell
25,539
-2,142
-8% -$392K 0.04% 142
2019
Q4
$5.46M Sell
27,681
-729
-3% -$136K 0.04% 139
2019
Q3
$5.11M Sell
28,410
-153
-0.5% -$26.5K 0.04% 139
2019
Q2
$4.99M Sell
28,563
-465
-2% -$79.7K 0.04% 140
2019
Q1
$5.52M Sell
29,028
-780
-3% -$139K 0.05% 119
2018
Q4
$4.76M Sell
29,808
-30
-0.1% -$5.08K 0.05% 116
2018
Q3
$5.71M Sell
29,838
-96
-0.3% -$17K 0.07% 111
2018
Q2
$4.77M Sell
29,934
-708
-2% -$108K 0.05% 127
2018
Q1
$4.22M Sell
30,642
-774
-2% -$108K 0.05% 132
2017
Q4
$3.82M Sell
31,416
-255
-0.8% -$31.9K 0.04% 144
2017
Q3
$3.68M Sell
31,671
-90
-0.3% -$9.81K 0.04% 136
2017
Q2
$3.3M Sell
31,761
-1,656
-5% -$159K 0.04% 143
2017
Q1
$2.85M Sell
33,417
-225
-0.7% -$17.8K 0.03% 151
2016
Q4
$2.37M Sell
33,642
-1,170
-3% -$86K 0.03% 162
2016
Q3
$2.8M Buy
34,812
+45
+0.1% +$3.45K 0.03% 140
2016
Q2
$2.56M Hold
34,767
0.03% 148
2016
Q1
$2.32M Sell
34,767
-576
-2% -$35.7K 0.03% 158
2015
Q4
$2.15M Sell
35,343
-288
-0.8% -$16.2K 0.03% 163
2015
Q3
$1.82M Hold
35,631
0.03% 173
2015
Q2
$1.92M Sell
35,631
-18,000
-34% -$1.01M 0.03% 180
2015
Q1
$3.01M Sell
53,631
-10,710
-17% -$606K 0.04% 145
2014
Q4
$3.78M Hold
64,341
0.05% 130
2014
Q3
$3.3M Sell
64,341
-1,080
-2% -$53.6K 0.05% 138
2014
Q2
$2.99M Sell
65,421
-4,104
-6% -$181K 0.05% 147
2014
Q1
$3.38M Sell
69,525
-6,120
-8% -$288K 0.05% 132
2013
Q4
$3.23M Sell
75,645
-3,546
-4% -$149K 0.05% 136
2013
Q3
$3.31M Sell
79,191
-3,861
-5% -$171K 0.06% 125
2013
Q2
$4.67M Buy
+83,052
New +$4.57M 0.09% 108

Other funds holding ISRG

Bahl & Gaynor's ISRG Position: Q1 2026 in Review

Bahl & Gaynor reduced its Intuitive Surgical (ISRG) stake by 7.6% in Q1 2026, selling an estimated $355K and leaving 8,554 shares worth $3.94M. The position accounts for 0.02% of the portfolio, ranked #181.

Bahl & Gaynor first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.71M in Q3 2018. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Bahl & Gaynor held 8,554 shares of Intuitive Surgical worth $3.94M as of Q1 2026.
  • Bahl & Gaynor sold 702 Intuitive Surgical shares in Q1 2026, an estimated $355K.
  • Intuitive Surgical made up 0.02% of Bahl & Gaynor's portfolio in Q1 2026, its #181 holding.
  • Bahl & Gaynor first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
  • Bahl & Gaynor's Intuitive Surgical position peaked at $5.71M in Q3 2018.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.